Relationship Between Potential Predictors and Mortality in COVID-19 Patients ın Turkey

Sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey (Other)

Overall Status

Completed

CT.gov ID

NCT04789460

Collaborator

(none)

816

Enrollment

Location

Actual Duration (Days)

1079.9

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In this study, the investigators planned to examine the laboratory characteristics of patients hospitalized with the diagnosis of Covid-19 and to investigate their relationship with mortality.

Condition or Disease	Intervention/Treatment	Phase
Covid19

Detailed Description

SARS-CoV-2 infection is effective in many countries and has caused pandemics. It is observed that it affects patients in a wide spectrum in terms of their clinical features worldwide. It is known that age, gender, and comorbidity play an important role in the course of the disease. Although mortality rates vary from country to country, there is no clear information due to the fact that the pandemic has not yet ended. In this study, the investigators planned to examine the laboratory characteristics of patients hospitalized with the diagnosis of Covid-19 and to investigate their relationship with mortality in Istanbul city which is the most affected by the pandemic in Turkey

Study Design

Study Type:

Observational

Actual Enrollment :

816 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Relationship Between Potential Predictors and Mortality in COVID-19 Patients in Turkey: A New Prognostic Model

Actual Study Start Date :

Mar 5, 2021

Actual Primary Completion Date :

Mar 28, 2021

Actual Study Completion Date :

Mar 28, 2021

Arms and Interventions

Arm	Intervention/Treatment
COVID-19 patients in hospital All patients aged 18 years and over, positive for SARS-CoV-2 PCR test and / or Covid-19 treatment with signs of Covid-19 disease on CT in two tertier hospital in Istanbul

Outcome Measures

Primary Outcome Measures

mortality rate [up to 30 days]
up to 30 days after discharge

Secondary Outcome Measures

need for intensive care unit rate [up to 30 days]
need for intensive care unit during hospitalization
length stay in hospital [up to 30 days]
number of length stay in hospital

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

All patients who are 18 years of age and older, positive for SARS-CoV-2 PCR test and / or Covid-19 disease findings on CT will be included in the study.

Exclusion Criteria:

Patients with negative SARS-CoV-2 PCR test, pneumonia on CT but not given Covid-19 treatment by not considering Covid-19 by their doctor will not be included.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	SBU Sultan Abdulhamid Han	Istanbul	Asia	Turkey	34668

Sponsors and Collaborators

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Investigators

Principal Investigator: Elif Yıldırım Ayaz, M.D., Sultan Abdülhamid Han Training and Rsearch Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

ClinicalTrials.gov Identifier:

NCT04789460

Other Study ID Numbers:

TURKEYPROMOD

First Posted:

Mar 9, 2021

Last Update Posted:

May 24, 2021

Last Verified:

May 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Additional relevant MeSH terms:

COVID-19

Study Results

No Results Posted as of May 24, 2021